Head of Advocacy & Market Development, COPD

At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big, and working together to make the impossible a reality. We are committed to leading a revolution in healthcare to address the unmet needs of patients around the world. We follow the science to better understand disease and its complexities so that we can discover, develop and deliver life‑changing treatments that improve outcomes for patients worldwide.

The Bio Pharmaceuticals business is one of the fastest growing areas within AstraZeneca. Through our relentless pursuit of innovation, we are transforming the way chronic diseases are understood, diagnosed, and treated. We deliver on the promise of our science through exceptional launch execution, impactful partnerships, and a deep commitment to patients.

We have an exciting opportunity for a Head of Advocacy & Market Development, to join our Global Commercial team and play a pivotal role in shaping the future of COPD care.

In this highly visible leadership role, you will lead the development and execution of global advocacy and market development strategies for a key launch asset in our respiratory portfolio. Working across global, regional, and local teams, you will help build scientific and clinical advocacy for IL‑33 pathway science while driving healthcare system transformation initiatives designed to improve patient identification, optimise care pathways, and expand access to innovative treatment approaches.

You will collaborate closely with Medical, Policy, Market Access, Digital, Commercial and local market teams to ensure strategy alignment and seamless execution across key global markets. Through strong external partnerships and expert engagement, you will help create the conditions needed to improve outcomes for patients living with COPD.

As a key member of the Global Commercial team, you will provide strategic leadership across advocacy, healthcare system change and market development initiatives that support the successful launch and long‑term growth of the asset.

• Develop and execute the global advocacy vision, strategy and operational plans to amplify the scientific and clinical narrative around IL‑33 pathway innovation
• Build and maintain strong partnerships with Key External Experts (KEEs), including leadership of the Global COPD Clinical Expert Council and related respiratory disease forums
• Collaborate with Global Brand Team colleagues to develop advocacy programs, educational initiatives, speaker training and engagement activities
• Partner closely with local market advocacy leads to ensure global strategies are effectively translated into local execution plans
• Develop tailored engagement plans for priority global advocates and strengthen AstraZeneca’s presence across respiratory and immunology communities

• Define and drive the long‑term global market development vision for COPD asset
• Lead the development of global market shaping strategies, tactics and assets in partnership with key markets
• Collaborate with Medical and Policy colleagues to develop healthcare system change initiatives focused on early patient identification, screening, care pathway optimisation and evidence generation
• Partner with external stakeholders, including healthcare authorities, patient advocacy organisations and policymakers, to advance COPD care delivery
• Identify and coordinate external partners and vendors that support patient identification and healthcare transformation programs
• Lead cross‑functional global and local teams to ensure successful planning and execution of market development initiatives
• Define and deliver compelling value propositions and service platform offerings that…